An Honest Conversation About the Pros and Cons of Ozempic for Adults with Dr. Tyna Moore

Dhru Purohit Show

Dhru Purohit

Medicine, Health & Fitness, Alternative Health

4.7 • 3.4K Ratings

🗓️ 8 July 2024

⏱️ 110 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This episode is brought to you by LMNT, Lifeforce, and Lumebox. The conversation around GLP-1 agonists has often been one-sided and biased by mainstream media, leading to myths about who should use these drugs, how they should be prescribed, and their side effects. Today’s guest offers a more comprehensive perspective on these medications and discusses her nuanced approach to using them to promote overall health and longevity. Today, on The Dhru Purohit Show, Dhru sits down with Dr. Tyna Moore to delve deep into GLP-1 agonists like Ozempic. Dr. Moore breaks down the research surrounding these drugs and offers a fresh perspective on their prescription and management. She discusses the criticisms skeptics have, myths about their proper use, and the lesser-known benefits of micro-dosing. Additionally, she explores the concept of GLP-1 deficiency and explains her motivation for creating an educational course on these drugs for both laypeople and practitioners. Dr. Tyna Moore is a board-certified naturopathic and chiropractic physician and the founder and owner of Core Wellness Clinic in Portland, Oregon. She specializes in non-surgical pain management, natural pain solutions, and regenerative injection therapies for orthopedic and musculoskeletal conditions. Moore has a Doctor of Naturopathic Medicine (N.D.) from the Western States Chiropractic College and a Doctor of Chiropractic (D.C.) from the National College of Naturopathic Medicine. In this episode, Dhru and Dr. Tyna Moore dive into (audio version / Apple Subscriber version): The lies and myths we are being told about Ozempic (00:00:16 / 00:00:16) Dr. Tyna’s mission to set the record straight (3:50 / 3:50) What the skeptics say about Ozempic (10:53 / 7:40) Where the GLP-1 agonist medications originated from (17:58 / 14:45) Benefits of taking the medications (26:32 / 21:32) Are people suffering from a GLP-1 deficiency (34:40/ 29:40) More than just calories in and out (52:30 / 47:30) Dr. Moore’s story on micro-dosing GLP-1s and the benefits she experienced (1:01:50 / 56:50) Concerns or myths about stopping these medications (1:07:40 / 1:02:40) Dr. Tyna’s education courses for laypersons and practitioners (1:20:00 / 1:15:00) Concerns about the obesity epidemic and lack of education (1:28:30 / 1:23:30) A national effort to address the childhood obesity crisis (1:40:10 / 1:35:10) Final Thoughts (1:45:30 / 1:40:30) Also mentioned in this episode: Dr. Tyna’s Podcast Dr. Tyna’s course For more on Dr. Moore, follow her on Instagram, YouTube, or her website. This episode is brought to you by LMNT, Lifeforce, and Lumebox. Right now, LMNT is offering my listeners a free sample pack with any purchase. Head over to DrinkLMNT.com/dhru today. Right now, you can save $250 on your first diagnostic and get personalized suggestions. Optimize your longevity and track your progress; go to mylifeforce.com/dhru! Lumebox is offering my community $260 off their FDA-approved portable Red Light device! That's over 50% off! Go to thelumebox.com/dhru and get your Red Light device. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Dr. Tina, you feel pretty strongly that we are being lied to about the side effects of drugs
0:08.8	like Osmpick and the place and role that they have in helping people truly get healthy.
0:16.5	So I'd love to start off a big picture.
0:18.4	What are some of those lies that we're all hearing and more importantly, why do you think we're being lied to?
0:24.6	Number one I think the biggest lie I'm hearing that I'm I'm really done with is the
0:29.5	induces muscle mass loss that is a misn The amount, the percentage of muscle loss is right in sync with any colorically restricted
0:39.7	diet.
0:40.7	It's right in sync with bariatric surgery. Anytime you put somebody into a
0:44.6	malnourished state you don't protect their muscle by prioritizing their protein
0:48.8	macros by having them strength train you're going to see muscle mass loss. The interesting part of
0:54.5	that to go one step further is that they're actually looking at lean mass
0:58.6	loss and lean mass is all of your soft tissues. That's the number they're reporting. Muscle is part of your
1:06.5	lean mass loss, but there are fatty infiltrates in the liver, in the pancreas, in the muscles, in folks who are metabolically unsound or suffering with obesity and or, and when they lose that with the use of G. L.P. 1 agonists, they're measuring that loss too. So it's a more in-depth conversation that we're not
1:25.5	really getting fleshed out in the studies. So I think that's the biggest one. The
1:30.7	other one that I think has been put to bed recently is the thyroid cancer risk.
1:35.0	The studies coming out on that have been correlative, not causative.
1:38.8	They're looking at patients who are already having the struggles with type 2 diabetes already diagnosed with obesity and then they are being put on a G.P. 1 agonist.
1:49.5	They're looking at their medical records.
1:51.5	That group of folks are already at high risk for thyroid cancer at a higher risk
1:56.7	than their lean counterparts. But even then, it's correlative, not causative.
2:01.6	And the interesting thing about the black box warning is that it was done on rats if you actually go in and look at it
2:07.2	It was done on rats these rats were given incredibly high doses and what they don't tell you is that the control group of rats also
	...

Transcript will be available on the free plan in -222 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Dhru Purohit, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dhru Purohit and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.